---
title: "000403.SZ (000403.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000403.SZ/news.md"
symbol: "000403.SZ"
name: "000403.SZ"
parent: "https://longbridge.com/en/quote/000403.SZ.md"
datetime: "2026-03-16T23:23:45.972Z"
locales:
  - [en](https://longbridge.com/en/quote/000403.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000403.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000403.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/000403.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000403.SZ/news.md)


# 000403.SZ (000403.SZ) — Related News

### [CITIC Construction Investment | 2025 Overview of the Blood Products Industry: The proportion of domestic albumin batch approvals increases, and the development of new products continues to advance](https://longbridge.com/en/news/276006811.md)
*2026-02-15T13:13:05.000Z*
> The research report from CITIC Construction Investment Securities indicates that the domestic blood products industry wi

### [PLBIO: The clinical trial application for the registration of human thrombin drug has been accepted](https://longbridge.com/en/news/274935360.md)
*2026-02-05T08:01:11.000Z*
> PLBIO announced that its wholly-owned subsidiary, Guangdong Shuanglin Biopharmaceutical Co., Ltd., has received the "Acc

### [PLBIO's subsidiary has obtained the drug registration and marketing license for human coagulation factor IX](https://longbridge.com/en/news/274779232.md)
*2026-02-04T08:24:16.000Z*
> PLBIO's wholly-owned subsidiary, Guangdong Shuanglin Biopharmaceutical Co., Ltd., has obtained the drug registration and

### [PLBIO: The subsidiary has received the acceptance notice for the supplemental application of intravenous immunoglobulin drugs](https://longbridge.com/en/news/274626763.md)
*2026-02-03T09:06:23.000Z*
> PLBIO's wholly-owned subsidiary, Guangdong Shuanglin Biopharmaceutical Co., Ltd., recently received the acceptance notic

### [Behind ZhanYan Biotech's IPO sprint, there was a significant "reshuffle" among distributors!](https://longbridge.com/en/news/274174775.md)
*2026-01-29T15:24:11.000Z*
> ZhanYan Biotechnology Co., Ltd. (ZhanYan Bio) is sprinting towards the Beijing Stock Exchange, and the background of its

### [Is it too late for Zhenyan Biotechnology to launch its IPO plan?](https://longbridge.com/en/news/273082747.md)
*2026-01-20T12:15:12.000Z*
> ZhanYan Biotechnology Co., Ltd. has initiated listing guidance and signed an agreement with China International Capital 

### [](https://longbridge.com/en/news/270675881.md)
*2025-12-24T01:53:46.000Z*
> The A-share biopharmaceutical sector fluctuated and rose, with PLBIO up over 8%. Other stocks such as BTBP, BOYA BIOLOGY